Publication:
Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder

Issued Date

2007-01-01

Resource Type

Article

ISSN

01252208
01252208

Other identifier(s)

2-s2.0-33847002316

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Journal of the Medical Association of Thailand. Vol.90, No.1 (2007), 179-181

Suggested Citation

Harirak Wanmuang, Juvady Leopairut, Chomsri Kositchaiwat, Winai Wananukul, Sukhum Bunyaratvej Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. Journal of the Medical Association of Thailand. Vol.90, No.1 (2007), 179-181. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/25047

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder

Author(s)

Harirak Wanmuang
 Juvady Leopairut
 Chomsri Kositchaiwat
 Winai Wananukul
 Sukhum Bunyaratvej

Other Contributor(s)

Mahidol University
 Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Abstract

Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/25047

Collections

Scopus 2006-2010